Ausgabe 1/2012
Inhalt (32 Artikel)
Are viruses associated with human breast cancer? Scrutinizing the molecular evidence
Deepti Joshi, Gertrude Case Buehring
Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?
Lian-Ming Wu, Jia-Ni Hu, Hai-Yan Gu, Jia Hua, Jie Chen, Jian-Rong Xu
Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma
Mark N. Jabbour, Cleo Y. Massad, Fouad I. Boulos
Therapeutic implications of estrogen receptor signaling in HER2-positive breast cancers
Rita Nahta, Ruth M. O’Regan
Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification
Robert Kornegoor, Cathy B. Moelans, Anoek H. J. Verschuur-Maes, Marieke C. H. Hogenes, Peter C. de Bruin, Joost J. Oudejans, Luigi Marchionni, Paul J. van Diest
Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression
Judy Pang, Kathy A. Toy, Ken A. Griffith, Baffour Awuah, Solomon Quayson, Lisa A. Newman, Celina G. Kleer
NFκB signaling is important for growth of antiestrogen resistant breast cancer cells
Christina W. Yde, Kristina B. Emdal, Barbara Guerra, Anne E. Lykkesfeldt
Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor
Elizabeth Iorns, Toby M. Ward, Sonja Dean, Anna Jegg, Dafydd Thomas, Nirupa Murugaesu, David Sims, Costas Mitsopoulos, Kerry Fenwick, Iwanka Kozarewa, Cristina Naceur-Lombarelli, Marketa Zvelebil, Clare M. Isacke, Christopher J. Lord, Alan Ashworth, H. James Hnatyszyn, Mark Pegram, Marc Lippman
Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation
Yong Hannah Wen, Alice Ho, Sujata Patil, Muzaffar Akram, Jeff Catalano, Anne Eaton, Larry Norton, Robert Benezra, Edi Brogi
Auto-acetylation stabilizes p300 in cardiac myocytes during acute oxidative stress, promoting STAT3 accumulation and cell survival
Sumit Jain, Jianqin Wei, Lindsay R. Mitrani, Nanette H. Bishopric
Nuclear nano-morphology markers of histologically normal cells detect the “field effect” of breast cancer
Rajan K. Bista, Pin Wang, Rohit Bhargava, Shikhar Uttam, Douglas J. Hartman, Randall E. Brand, Yang Liu
Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancer
Sylvie M. Noordermeer, Marloes Wennemers, Saskia M. Bergevoet, Adrian van der Heijden, Evelyn Tönnissen, Fred C. G. J. Sweep, Joop H. Jansen, Paul N. Span, Bert A. van der Reijden
BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients
Jasmina Z. Cerne, Lin Zong, Jaroslav Jelinek, Susan G. Hilsenbeck, Tao Wang, Steffi Oesterreich, Sean E. McGuire
Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology
Marek Ancukiewicz, Cynthia L. Miller, Melissa N. Skolny, Jean O’Toole, Laura E. Warren, Lauren S. Jammallo, Michelle C. Specht, Alphonse G. Taghian
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression
Ana Cristina Vargas, Amy E. McCart Reed, Nic Waddell, Annette Lane, Lynne E. Reid, Chanel E. Smart, Sibylle Cocciardi, Leonard da Silva, Sarah Song, Georgia Chenevix-Trench, Peter T. Simpson, Sunil R. Lakhani
A 24-color metaphase-based radiation assay discriminates heterozygous BRCA2 mutation carriers from controls by chromosomal radiosensitivity
Alexandra A. Becker, Monika K. Graeser, Christina Landwehr, Thomas Hilger, Wolfgang Baus, Barbara Wappenschmidt, Alfons Meindl, Ruthild G. Weber, Rita K. Schmutzler
High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers
G. L. Chew, D. Huang, S. J. Lin, C. Huo, T. Blick, M. A. Henderson, P. Hill, J. Cawson, W. A. Morrison, I. G. Campbell, J. L. Hopper, M. C. Southey, I. Haviv, E. W. Thompson
111In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer
Aisha Fasih, Humphrey Fonge, Zhongli Cai, Jeffrey V. Leyton, Ilia Tikhomirov, Susan J. Done, Raymond M. Reilly
Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors
Yong Soon Chun, Takahiro Yoshida, Tsuyoshi Mori, David L. Huso, Zhe Zhang, Vered Stearns, Brandy Perkins, Richard J. Jones, Saraswati Sukumar
Intraoperative ultrasound guidance for excision of non-palpable invasive breast cancer: a hospital-based series and an overview of the literature
M. W. Barentsz, T. van Dalen, P. D. Gobardhan, V. Bongers, C. I. Perre, R. M. Pijnappel, M. A. A. J. van den Bosch, H. M. Verkooijen
Predicting two-year quality of life after breast cancer surgery using artificial neural network and linear regression models
Hon-Yi Shi, Jinn-Tsong Tsai, Yao-Mei Chen, Richard Culbertson, Hong-Tai Chang, Ming-Feng Hou
Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy
Bas B. Koolen, Renato A. Valdés Olmos, Paula H. M. Elkhuizen, Wouter V. Vogel, Marie-Jeanne T. F. D. Vrancken Peeters, Sjoerd Rodenhuis, Emiel J. Th. Rutgers
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
Richard H. De Boer, Dusan Kotasek, Shane White, Bogda Koczwara, Paul Mainwaring, Arlene Chan, Rebeca Melara, Yining Ye, Adeboye H. Adewoye, Robert Sikorski, Peter A. Kaufman
Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A
Elena Sperk, Grit Welzel, Anke Keller, Uta Kraus-Tiefenbacher, Axel Gerhardt, Marc Sütterlin, Frederik Wenz
Statin use and risk of breast cancer: a meta-analysis of observational studies
Krishna Undela, Vallakatla Srikanth, Dipika Bansal
Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences
Annemiek B. G. Kwast, Karin C. G. M. Groothuis-Oudshoorn, Ilse Grandjean, Vincent K. Y. Ho, Adri C. Voogd, Marian B. E. Menke-Pluymers, Maurice J. C. van der Sangen, Vivianne C. G. Tjan-Heijnen, Lambertus A. Kiemeney, Sabine Siesling
Impact of comorbidity on management and mortality in women diagnosed with breast cancer
Anders Berglund, Annette Wigertz, Jan Adolfsson, Johan Ahlgren, Tommy Fornander, Fredrik Wärnberg, Mats Lambe
Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program
Solveig Hofvind, Christoph I. Lee, Joann G. Elmore
PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer
A. Prat, J. S. Parker, C. Fan, C. M. Perou
Feature extraction via composite scoring and voting in breast cancer
Martin Koch, Markus Hanl, Michael Wiese
MRI in residual tumor size measurement in patient with breast cancer receiving neoadjuvant chemotherapy calls for caution
Lian-Ming Wu, Jiani Hu, Jian-Rong Xu